Trilogy International Partners Inc (TSE:TRL) has been given a C$10.50 price target by equities research analysts at TD Securities in a research report issued to clients and investors on Friday. The firm currently has a “buy” rating on the specialty pharmaceutical company’s stock. TD Securities’ price objective indicates a potential upside of 34.62% from the company’s previous close.

Separately, Scotiabank reaffirmed an “outperform” rating and set a C$13.00 target price on shares of Trilogy International Partners in a research report on Monday, May 15th.

Trilogy International Partners (TRL) remained flat at $7.80 during midday trading on Friday. The stock had a trading volume of 700 shares. The company’s 50-day moving average price is $8.37 and its 200-day moving average price is $9.34. Trilogy International Partners has a 12-month low of $7.54 and a 12-month high of $10.48. The firm’s market capitalization is $331.60 million.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/08/11/trilogy-international-partners-inc-trl-given-a-c10-50-price-target-by-td-securities-analysts.html.

About Trilogy International Partners

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with MarketBeat.com's FREE daily email newsletter.